Key Takeaways
- Biotalys achieved its first research milestone with Syngenta in developing a novel bioinsecticide using its AGROBODY™ technology platform against key insect pests.
- Initial laboratory tests demonstrated promising in vitro results with novel bioactive ingredients developed against the insect molecular target.
- The collaboration will now proceed to the next research phase, testing active ingredients on living organisms in vivo studies.
- Syngenta will pay Biotalys a first milestone payment that will not materially impact the company's current cash runway, which extends until the end of May 2026.
- Biotalys is an AgTech company founded in 2013 as a VIB spin-off and is listed on Euronext Brussels under ticker BTLS.
Biotalys Partnership Advances Bioinsecticide Research
Biotalys, an Agricultural Technology company developing protein-based biocontrol solutions, has reached its first research milestone in partnership with Syngenta for developing a novel bioinsecticide against key insect pests. The Ghent, Belgium-based company announced that initial laboratory tests showed promising in vitro results using its proprietary AGROBODY™ technology platform.
The partnership addresses growing challenges in crop protection as insect resistance continues to rise alongside tightening regulatory and environmental constraints. Growers are increasingly seeking new solutions that remain effective over time while reducing environmental impact.
Technology Platform and Market Applications
Biotalys' protein-based biocontrols represent a new class of crop protection active ingredients designed to help growers manage resistant insect populations. The company's AGROBODY™ technology platform creates solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions.
4 Comments